The data obtained during the analysis of clinical blood samples for children acute lymphoblastic leukemia patients with severe side-effects

The present work contains data obtained during the analysis of blood samples obtained from patients (number: 102, age: 0–2 years old) with confirmed acute lymphoblastic leukemia diagnosis. Among these total number, 48 patients who received a chemotherapy including 9 patients with side-effects were c...

Descripción completa

Detalles Bibliográficos
Autores principales: Zyubin, Andrey, Lavrova, Anastasiya, Demin, Maksim, Pankina, Alina, Babak, Svetlana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Data Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5361767/
https://www.ncbi.nlm.nih.gov/pubmed/28367481
http://dx.doi.org/10.1016/j.dib.2017.03.016
_version_ 1782516829224173568
author Zyubin, Andrey
Lavrova, Anastasiya
Demin, Maksim
Pankina, Alina
Babak, Svetlana
author_facet Zyubin, Andrey
Lavrova, Anastasiya
Demin, Maksim
Pankina, Alina
Babak, Svetlana
author_sort Zyubin, Andrey
collection PubMed
description The present work contains data obtained during the analysis of blood samples obtained from patients (number: 102, age: 0–2 years old) with confirmed acute lymphoblastic leukemia diagnosis. Among these total number, 48 patients who received a chemotherapy including 9 patients with side-effects were chosen. Final data include a table of protein masses (biomarkers of pathological processes at the chemotherapy) obtained by the MALDI-TOF spectroscopy from blood of 9 chosen patients (0–2 years old).
format Online
Article
Text
id pubmed-5361767
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-53617672017-03-31 The data obtained during the analysis of clinical blood samples for children acute lymphoblastic leukemia patients with severe side-effects Zyubin, Andrey Lavrova, Anastasiya Demin, Maksim Pankina, Alina Babak, Svetlana Data Brief Data Article The present work contains data obtained during the analysis of blood samples obtained from patients (number: 102, age: 0–2 years old) with confirmed acute lymphoblastic leukemia diagnosis. Among these total number, 48 patients who received a chemotherapy including 9 patients with side-effects were chosen. Final data include a table of protein masses (biomarkers of pathological processes at the chemotherapy) obtained by the MALDI-TOF spectroscopy from blood of 9 chosen patients (0–2 years old). Elsevier 2017-03-12 /pmc/articles/PMC5361767/ /pubmed/28367481 http://dx.doi.org/10.1016/j.dib.2017.03.016 Text en © 2017 The Authors http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Data Article
Zyubin, Andrey
Lavrova, Anastasiya
Demin, Maksim
Pankina, Alina
Babak, Svetlana
The data obtained during the analysis of clinical blood samples for children acute lymphoblastic leukemia patients with severe side-effects
title The data obtained during the analysis of clinical blood samples for children acute lymphoblastic leukemia patients with severe side-effects
title_full The data obtained during the analysis of clinical blood samples for children acute lymphoblastic leukemia patients with severe side-effects
title_fullStr The data obtained during the analysis of clinical blood samples for children acute lymphoblastic leukemia patients with severe side-effects
title_full_unstemmed The data obtained during the analysis of clinical blood samples for children acute lymphoblastic leukemia patients with severe side-effects
title_short The data obtained during the analysis of clinical blood samples for children acute lymphoblastic leukemia patients with severe side-effects
title_sort data obtained during the analysis of clinical blood samples for children acute lymphoblastic leukemia patients with severe side-effects
topic Data Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5361767/
https://www.ncbi.nlm.nih.gov/pubmed/28367481
http://dx.doi.org/10.1016/j.dib.2017.03.016
work_keys_str_mv AT zyubinandrey thedataobtainedduringtheanalysisofclinicalbloodsamplesforchildrenacutelymphoblasticleukemiapatientswithseveresideeffects
AT lavrovaanastasiya thedataobtainedduringtheanalysisofclinicalbloodsamplesforchildrenacutelymphoblasticleukemiapatientswithseveresideeffects
AT deminmaksim thedataobtainedduringtheanalysisofclinicalbloodsamplesforchildrenacutelymphoblasticleukemiapatientswithseveresideeffects
AT pankinaalina thedataobtainedduringtheanalysisofclinicalbloodsamplesforchildrenacutelymphoblasticleukemiapatientswithseveresideeffects
AT babaksvetlana thedataobtainedduringtheanalysisofclinicalbloodsamplesforchildrenacutelymphoblasticleukemiapatientswithseveresideeffects
AT zyubinandrey dataobtainedduringtheanalysisofclinicalbloodsamplesforchildrenacutelymphoblasticleukemiapatientswithseveresideeffects
AT lavrovaanastasiya dataobtainedduringtheanalysisofclinicalbloodsamplesforchildrenacutelymphoblasticleukemiapatientswithseveresideeffects
AT deminmaksim dataobtainedduringtheanalysisofclinicalbloodsamplesforchildrenacutelymphoblasticleukemiapatientswithseveresideeffects
AT pankinaalina dataobtainedduringtheanalysisofclinicalbloodsamplesforchildrenacutelymphoblasticleukemiapatientswithseveresideeffects
AT babaksvetlana dataobtainedduringtheanalysisofclinicalbloodsamplesforchildrenacutelymphoblasticleukemiapatientswithseveresideeffects

Ejemplares similares